Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gonzalez-Bocco IH"'
Autor:
Loy C; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA.; Department of Molecular Biology and Genetics, Cornell University; Ithaca, 14853, USA., Cheng MP; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, 02215, USA.; Division of Infectious Disease, Brigham and Women's Hospital; Boston, 02215, USA., Gonzalez-Bocco IH; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, 02215, USA.; Division of Infectious Disease, Brigham and Women's Hospital; Boston, 02215, USA., Lenz J; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA., Belcher E; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA., Bliss A; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA., Eweis-LaBolle D; Department of Molecular Biology and Genetics, Cornell University; Ithaca, 14853, USA., Chu T; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute; Boston, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, 02115, USA., De Vlaminck I; Meinig School of Biomedical Engineering, Cornell University; Ithaca, 14850, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 16. Date of Electronic Publication: 2024 May 16.
Autor:
Gonzalez-Bocco IH; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Isabel_gonzalez-bocco@dfci.harvard.edu., Beluch K; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Cho A; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Lahoud C; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Reyes FA; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Moshovitis DG; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Unger-Mochrie GM; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA., Wang W; Harvard Medical School, Boston, MA, USA.; Medicine Department, Brigham and Women's Hospital, Boston, MA, USA., Hammond SP; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA., Manne-Goehler J; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Infectious Disease, Massachusetts General Hospital, Boston, MA, USA., Koo S; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, MA, USA. skoo@bwh.harvard.edu.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA, USA. skoo@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. skoo@bwh.harvard.edu.
Publikováno v:
Pilot and feasibility studies [Pilot Feasibility Stud] 2023 Jun 16; Vol. 9 (1), pp. 100. Date of Electronic Publication: 2023 Jun 16.
Autor:
Aleissa MM; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Electronic address: Muneerah_aleissa@dfci.harvard.edu., Little JS; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Davey S; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Saucier A; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zhou G; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Gonzalez-Bocco IH; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Crombie JL; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Looka A; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Issa NC; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Hammond SP; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Jacobson CA; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Sherman AC; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jun; Vol. 29 (6), pp. 398.e1-398.e5. Date of Electronic Publication: 2023 Mar 09.
Autor:
Little JS; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA., Aleissa MM; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.; Department of Pharmacy, Brigham and Women's Hospital, Boston, MA., Beluch K; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA., Gonzalez-Bocco IH; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA., Marty FM; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA., Manne-Goehler J; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and., Koo S; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA., Hammond SP; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; and.; Division of Hematology and Oncology, Massachusetts General Cancer Center, Boston, MA., Jacobson CA; Harvard Medical School, Boston, MA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2022 Aug 23; Vol. 6 (16), pp. 4821-4830.
Autor:
Aleissa MM; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gonzalez-Bocco IH; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zekery-Saad S; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Kubiak DW; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zhang EM; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Signorelli J; Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts, USA., Hammond SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Mohareb AM; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Harvard Medical School, Boston, Massachusetts, USA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Manne-Goehler J; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Marty FM; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Jun 20; Vol. 9 (8), pp. ofac306. Date of Electronic Publication: 2022 Jun 20 (Print Publication: 2022).
Autor:
Gonzalez-Bocco IH; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Aleissa MM; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Zhou E; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA., Manne-Goehler J; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA., Koo S; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Cheng MP; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; Division of Medical Microbiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.; McGill Interdisciplinary Initiative in Infection and Immunity, Montreal, Quebec, Canada., Marty FM; Division of Infectious Disease, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 18; Vol. 9 (1), pp. ofab582. Date of Electronic Publication: 2021 Dec 18 (Print Publication: 2022).
Autor:
Aleissa MM; Department of Pharmacy, Brigham and Women's Hospital, United States; Division of Infectious Disease, Dana-Farber Cancer Institute and Brigham and Women's Hospital, United States., Alshehri BS; Department of Pharmacy, Brigham and Women's Hospital, United States., Gonzalez-Bocco IH; Division of Infectious Disease, Dana-Farber Cancer Institute and Brigham and Women's Hospital, United States; Havard Medical School, United States., McDonnell AM; Department of Pharmacy, Brigham and Women's Hospital, United States., Leblebjian H; Department of Pharmacy, Dana-Farber Cancer Institute, United States., Marty FM; Division of Infectious Disease, Dana-Farber Cancer Institute and Brigham and Women's Hospital, United States; Havard Medical School, United States., Luskin MR; Havard Medical School, United States; Division of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, United States. Electronic address: Marlise_Luskin@DFCI.HARVARD.EDU.
Publikováno v:
Leukemia research [Leuk Res] 2021 Sep; Vol. 108, pp. 106610. Date of Electronic Publication: 2021 May 25.